Strategic partnerships Tecan is actively forming and highlighting partnerships with leaders in biotech and healthcare, such as HP, BioSkryb, Cutiss, and SLAS-related collaborators. This indicates receptive channels for co-developed automation solutions and jointly marketed offerings.

Automation leadership Recent launches and demonstrations of Veya and ongoing SLAS participation position Tecan as a state-of-the-art automation provider. There is a clear opportunity to upsell advanced liquid handling systems and integrated software to labs expanding high-throughput capabilities.

Single-cell focus Strategic collaborations around single-cell sequencing workflows suggest demand for automation tuned to high-throughput library prep and cell isolation. Sales opportunities exist in scalable turnkey solutions for genomics and regenerative medicine pipelines.

Clinical and life sciences convergence Tecan’s mission spans from life science to clinic, with a strong emphasis on compliant, reproducible processes. Target customers include biotechs and contract research organizations seeking validated workflows, enabling cross-sell into clinical sample processing and diagnostic support.

Scale and efficiency With a mid-market size and revenue between 500M and 1B, Tecan appeals to growing laboratories seeking efficiency gains. There is an opportunity to position end-to-end automation packages, service contracts, and migration paths to more integrated platforms as labs scale.